Nuformix plc Return on Equity

Nuformix plc (NFX.L) currently reports a ROE of -283.37%. That is below the Healthcare sector average of 13.1%. Use the charts on this page to explore Nuformix plc's ROE history and peer comparisons.

Nuformix plc's ROE of -283.37% is lower than the Healthcare sector average of 13.1%. That is roughly 2262.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Nuformix plc's current -283.37% should be judged against Healthcare norms (sector average: 13.1%) and against NFX.L's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -283.37%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.1%. From there, open related valuation or income-statement pages for Nuformix plc, and consider following NFX.L for alerts when major investors trade the stock.

Nuformix plc is classified in the Healthcare sector. On ROE, it currently shows -283.37% versus a sector average near 13.1%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NFX.L with unrelated industries.